TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
BVS

Bioventus Inc

Healthcare · Medical Devices

10.90$ -16.8% vs. previous close Closing price · As of: Nov 3, 2026

Ownership

Ownership Structure

Who owns Bioventus Inc (BVS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 50.2% of the shares are freely tradable; institutional investors hold 78.3%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 78.3%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 11.7%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 50.2%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 6.8%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 68Mio.

Largest Shareholders

Institutions

Institutions BVS
Name Stake (%) Shares Change (%) Date
Essex Woodlands Health Ventures 19.06 13,021,324 +0.0 06/30/2026
Nantahala Capital Management, LLC 17.57 12,000,558 +96.0 06/30/2026
Juniper Investment Co, LLC 10.16 6,939,357 +0.0 06/30/2026
BlackRock Inc 5.03 3,435,914 +9.6 06/30/2026
Royce & Associates, LP 2.68 1,833,212 +18.9 06/30/2026
Vanguard Capital Management, LLC 2.56 1,751,678 +2.2 06/30/2026
Geode Capital Management, LLC 2.00 1,365,716 +16.9 06/30/2026
American Century Companies Inc 1.98 1,353,415 +118.4 06/30/2026

Funds

Funds BVS
Name Stake (%) Shares Change (%) Date
Avantis US Small Cap Value ETF 2.57 1,756,661 +0.4 09/30/2026
iShares Russell 2000 ETF 1.83 1,248,896 -1.1 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?